A Study of TQB3820 in Patients With Hematological Malignancies
Clinical trial NCT05020639 · UNKNOWN
Trial details
- NCT number
- NCT05020639
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2024-08-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.